
Module Pharmaceutical Private Limited
About Module Pharmaceutical Private Limited
Data last updated:
Module Pharmaceutical Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 24 February 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24100KA2012PTC062712. Its GSTIN is 29AAHCM7607D1ZE (Karnataka).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Shahabuddin Khan (Managing Director) and Iram Ismail.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No.208 Ground Floor 1st Main Road Chamarajpet, Bangalore, Karnataka, India – 560018.
As per the financials filed for FY 2025, the company reported a revenue of ₹87.14 Lakh, a growth of 27% compared to the previous year. For the same year it recorded a net profit of ₹1.62 Lakh (net margin 1.9%) and EBITDA of ₹2.63 Lakh (EBITDA margin 3%). Revenue has grown at a compounded annual rate (CAGR) of 19% over three years and 20% over five years.
Court records list 3 cases involving the company, including 3 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Module Pharmaceutical Private Limited's registered office is in Bangalore, Karnataka. Its e-mail address is in the company report.
- Email
- Registered AddressNo.208 Ground Floor 1st Main Road Chamarajpet, Bangalore, Karnataka, India – 560018
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Module Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Module Pharmaceutical is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Module Pharmaceutical Private Limited, buy the company report.
Financials of Module Pharmaceutical Private Limited
FY 2025 filings availableModule Pharmaceutical Private Limited reported revenue of ₹87.14 Lakh (up 27% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 20% over five years, including 27% growth in the latest year. EBITDA rose 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.63 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.62 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3% | ||||
| Net Profit Margin | 1.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Module Pharmaceutical Private Limited, buy the company report.
Board of directors of Module Pharmaceutical Private Limited
Module Pharmaceutical has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Iram Ismail | Director | 21 Nov 2016 | 9 Years 11 Months | Current |
| Shahabuddin Khan | Managing Director | 24 Feb 2012 | 14 Years 8 Months | Current |
Auditor
Module Pharmaceutical Private Limited is audited by IQBAL KHAN & CO LLP for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| IQBAL KHAN & CO LLP | FY 2022 | 001149S |
Shareholding
The shareholding of Module Pharmaceutical Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Module Pharmaceutical Private Limited, buy the company report.
Legal cases
Module Pharmaceutical Private Limited has 3 court cases on record: 3 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 3 | 0 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ahmedabad, Gujarat | Criminal complaint | Filed against the company by Kotak Mahindra Bank Ltd | Disposed |
| District court, Ahmedabad, Gujarat | Court case (CR EN) | Filed against the company by Kotak Mahindra Bank Ltd | Disposed |
| District court, BENGALURU, Karnataka | Execution petition | Filed against the company by Kotak Mahindra Bank Ltd., Rep by Savitha S Patil | Disposed |
To see the full case history of Module Pharmaceutical Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Module Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Module Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAHCM7607D1ZE | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Module Pharmaceutical Private Limited, buy the company report.
Recent activity
Module Pharmaceutical Private Limited has 5 board changes on record since 2012: 2 appointments and 3 cessations. The latest: Iram Ismail was appointed as Director on 21 Nov 2016.
Frequently asked questions
Module Pharmaceutical is an active private limited company based in Bangalore, Karnataka, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 24 February 2012 (14+ years old) and is registered under CIN U24100KA2012PTC062712.
Module Pharmaceutical has 2 current directors:
- Shahabuddin Khan - Managing Director
- Iram Ismail - Director
The latest financial statements of Module Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Module Pharmaceutical is 29AAHCM7607D1ZE, registered in Karnataka.
The CIN (Corporate Identification Number) of Module Pharmaceutical is U24100KA2012PTC062712. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Module Pharmaceutical has 3 court cases on record: 3 filed against it.
Module Pharmaceutical was incorporated on 24 February 2012, making it 14+ years old. It is registered with the Registrar of Companies, Bangalore.
Iram Ismail was appointed as Director on 21 Nov 2016. Shamshuddin Khan ceased to be Director on 21 Nov 2016. Shahabuddin Khan ceased to be Director on 02 Feb 2013. Module Pharmaceutical has 5 board changes on record in total.
The registered office of Module Pharmaceutical is at No.208 Ground Floor 1st Main Road Chamarajpet, Bangalore, Karnataka, India – 560018.
Module Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

